Qualigens Pharma Private Limited

Qualigens Pharma Private Limited - pharma in Khalapur, Maharashtra, India. FY 2026 financials and compliance.
CIN U24100MH2013PTC249071 Incorporated 10 October 2013 ROC Mumbai HQ Khalapur, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹214.78 Cr
▲ 13.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.55 Cr
Issued & subscribed
Open charges
₹48.99 Cr
Secured borrowings
Company age
13 yrs
Est. 2013
Employees · EPFO
226
Latest available

About Qualigens Pharma Private Limited

Data last updated: 21 December 2025

Qualigens Pharma Private Limited is a private limited company based in Khalapur, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 10 October 2013, the company has been in operation for over 13 years.

Registered with ROC Mumbai under CIN U24100MH2013PTC249071.

Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.55 Cr. It is led by directors including Ajit Jain and Ankit Suresh Paharia.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Survey No. 151/2 At Village Umbre Khopoli Pali Road Taluka Khalapur, Maharashtra, India – 410206.

As per the financials filed for FY 2025, the company reported a revenue of ₹214.78 Cr, a growth of 13% compared to the previous year.

The company has a workforce of approximately 226 employees as per the latest available data.

The company is associated with 1 brand - Qualigens Pharma. As per MCA filings, the company has open charges of ₹48.99 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qualigenspharma.com.

Company Details of Qualigens Pharma Private Limited
CIN U24100MH2013PTC249071
Registration Number 249071
Incorporation Date 10 October 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
    Locked
  • Registered Address
    Survey No. 151/2 At Village Umbre Khopoli Pali Road Taluka Khalapur, Maharashtra, India – 410206
  • Industry
    Pharma, Drug Formulation & Development
Company report
Qualigens Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Qualigens Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Qualigens Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Qualigens Pharma Private Limited

Qualigens Pharma Private Limited operates one associated brand: Qualigens Pharma. These brands represent Qualigens Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Produces high-quality pharmaceutical tablets, capsules, and formulations for global partners. qualigenspharma.com

Competitors & Alternatives of Qualigens Pharma Private Limited

Brands and companies operating in the same space as Qualigens Pharma Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
Ascendis Pharma Ascendis Pharma Long-acting prodrug therapies are developed for endocrine and rare diseases. Hellerup, Denmark, Denmark 2007
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Qualigens Pharma Private Limited

Qualigens Pharma Private Limited is engaged in the principal business activity of professional, scientific and technical, with detailed activities including other professional, scientific and technical activities.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
M Professional, Scientific and Technical M9 Other professional, scientific and technical activities Locked
Premium access

Business activity turnover details for Qualigens Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Qualigens Pharma Private Limited

Qualigens Pharma Private Limited is audited by JAIN S P AND ASSOCIATES LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
JAIN S P AND ASSOCIATES LLP Locked Locked Locked
Premium access

Complete auditor history for Qualigens Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Qualigens Pharma Private Limited

Qualigens Pharma Private Limited is currently managed by 3 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Ajit Jain Director 10 Mar 2016 10 Years 5 Months Current
Ankit Suresh Paharia Director 10 Oct 2013 12 Years 10 Months Current
Aayush Jain Director 01 Aug 2017 9 Years 0 Months Current

Financials of Qualigens Pharma Private Limited FY 2025 filings available

Qualigens Pharma Private Limited reported revenue of ₹214.78 Cr (up 13.00% YoY) for FY 2025.

Revenue · FY 2025
₹214.78 Cr ▲ 13.00%
Premium access

Ten-year financial statements for Qualigens Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Qualigens Pharma Private Limited

Premium access

Shareholding and ownership data for Qualigens Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Qualigens Pharma Private Limited

Open charges
₹48.99 Cr
Satisfied charges
₹0
Breakdown by lending institutions
Others₹37.99 Cr
Axis Bank Limited₹11.00 Cr
Latest charge details
DateLenderAmountStatus
24 Jul 2024 Others ₹5 Cr Open
22 Apr 2021 Axis Bank Limited ₹11 Cr Open
27 Feb 2020 Others ₹2.24 Cr Open
17 Jul 2019 Others ₹30.75 Cr Open

Total charge records: 4 View all charges

Employees and EPFO Compliance at Qualigens Pharma Private Limited

Qualigens Pharma Private Limited has a workforce of 226 employees as of Apr 08, 2024.

Employee count
226
Active EPFO establishments
1
Employee growth
14.72%
Premium access

Employee and EPFO history for Qualigens Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Qualigens Pharma Private Limited

Premium access

GST registrations and filing compliance for Qualigens Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Qualigens Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Qualigens Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Qualigens Pharma Private Limited

Premium access

MSME payment history for Qualigens Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Qualigens Pharma Private Limited

Premium access

Corporate group structure for Qualigens Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Qualigens Pharma Private Limited

Premium access

MCA filings and documents for Qualigens Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Qualigens Pharma Private Limited

Activity
30 Sep 2025
Qualigens Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Qualigens Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
21 Mar 2025
A charge with Others of Rs. 5.00 Cr registered on 24 Jul 2024 with Charge ID 100963792 was modified on 21 Mar 2025.
Charges
21 Mar 2025
A charge with Others of Rs. 30.75 Cr registered on 17 Jul 2019 with Charge ID 100275914 was modified on 21 Mar 2025.
Charges
24 Jul 2024
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100963792 was registered on 24 Jul 2024.
Charges
22 Apr 2021
A charge with Axis Bank Limited amounted to Rs. 11.00 Cr with Charge ID 100451504 was registered on 22 Apr 2021.

Frequently Asked Questions about Qualigens Pharma Private Limited

Qualigens Pharma Private Limited is an active private limited company in the pharma sector based in Khalapur, Maharashtra, India. It was incorporated on 10 October 2013 (13+ years old) and is registered under CIN U24100MH2013PTC249071. The company has 226 employees.

Qualigens Pharma Private Limited reported revenue of ₹214.78 Cr for FY 2025 (up 13.00% YoY).

The current directors of Qualigens Pharma Private Limited are:

The primary industry of Qualigens Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Qualigens Pharma Private Limited can be reached at the registered office: Survey No. 1512 At Village Umbre Khopoli Pali Road Taluka Khalapur, Maharashtra, India – 410206, or through the website qualigenspharma.com.

The authorised capital is ₹2 Cr, and the paid-up capital is ₹1.55 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available